<
 
 
 
 
×
>
hide
You are viewing a Web site, archived on 21:31:10 Nov 08, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection. Note that this document was downloaded, and not saved because it was a duplicate of a previously captured version (22:09:07 Nov 07, 2004). HTTP headers presented here are from the original capture.
FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizonal rule
CBER links to product areas
CBER links
horizonal rule

Devices

horizonal rule

The Center for Biologics Evaluation and Research (CBER) regulates the medical devices involved in the collection, processing, testing, manufacture and administration of licensed blood, blood components and cellular products. CBER also regulates all HIV test kits used both to screen donor blood, blood components and cellular products, and to diagnose, treat and monitor persons with HIV and AIDs. CBER has developed a Device Action Plan to facilitate the device provisions of the 1997 Food and Drug Administration Modernization Act and to ensure consistency between the policies and procedures of CBER and FDA's Center for Devices and Radiological Health.

 

Topics

Device Action Plan

Devices Regulated by CBER

MDUFMA

Publications

Application Submission

Blood Estab Computer Software

HIV, HTLV & Hepatitis Tests

Frequently Asked Questions About the OraQuick Rapid HIV-1 Antibody Test

Updated January 29, 2004
 
horizonal rule

CBER Home Page | CBER A-Z Index | CBER Search | Contact CBER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA / Center for Biologics Evaluation and Research